Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements
This document provides guidance on establishment licensing, product quality and lot release to bring a COVID-19 vaccine to market in Canada.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2022-07-28
Data overview
- Formats
- HTML
- File languages
- English, French